VishalRameshDhereMD

Radiation Oncology • Atlanta, GA

Radiation Oncology

Join to view full profile

Dr. Dhere is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Dhere's full profile

Already have an account?

Office
1365 Clifton Rd NE Ste A1300
Atlanta, GA 30322
Phone+1 404-778-3473

Education & Training

Emory University School of MedicineResidency, Radiation Oncology, 2018 - 2022
Emory University School of MedicineClass of 2016

Certifications & Licensure

GA State Medical License 2022 - 2026
American Board of Radiology Radiation Oncology

Publications & Presentations

PubMed

Loss of immune cell identity with age inferred from large atlases of single cell transcriptomes.
Erin Connolly, Tony Pan, Maneesha Aluru, Sriram Chockalingam, Vishal Dhere
Aging Cell. 2024-12-01
Pre-operative stereotactic radiosurgery and peri-operative dexamethasone for resectable brain metastases: a two-arm pilot study evaluating clinical outcomes and immuno...
Caroline S Jansen, Meghana S Pagadala, Maria A Cardenas, Roshan S Prabhu, Subir Goyal
Nature Communications. 2024-10-14
Impact of Rectal Spacer on Toxicity Reduction in Men Treated With Proton Versus Photon Therapy.
Vishal R Dhere, Subir Goyal, Jun Zhou, Nikhil T Sebastian, Ashish B Patel
International Journal of Particle Therapy. 2024-09-01

Journal Articles

Analysis of Radiation Facility Volume and Survival in Men with Lymph Node–Positive Prostate Cancer Treated with Radiation and Androgen Deprivation Therapy
Pretesh R Patel, Sheela Hanasoge, Vishal R Dhere, Karen D Godette, Ashesh B Jani, Bruce Hershatter, JAMA Network Open

Press Mentions

ASTRO 2024: EMPIRE-2: Volumetric Changes and Acute Toxicity with 68Ga PSMA Versus 18F-Fluciclovine PET/CT Guided Post-Prostatectomy Radiation: Final Analysis of a Randomized TrialOctober 8th, 2024